Sabra Healthcare REIT (NASDAQ:SBRA) Hits New 1-Year High – What’s Next?

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA)’s stock price hit a new 52-week high on Thursday . The stock traded as high as $19.98 and last traded at $19.8980, with a volume of 1388371 shares changing hands. The stock had previously closed at $19.60.

Key Stories Impacting Sabra Healthcare REIT

Here are the key news stories impacting Sabra Healthcare REIT this week:

• Positive Sentiment: Company issued FY‑2026 EPS guidance of $1.550–$1.590, well above the consensus cited in releases (~$1.06), signaling management expects stronger earnings power next year. Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance
• Positive Sentiment: Q4 operating metrics showed growth in key cash flow measures: FFO $0.36 and AFFO $0.37, and revenue grew ~16% year-over-year to ~$201M — supports the raised FY outlook if trends persist. Sabra Reports Fourth Quarter 2025 Results; Introduces 2026 Guidance
• Neutral Sentiment: Management will attend Citi’s Global Property CEO Conference (Mar 1–4), providing investors an opportunity for additional color on guidance assumptions and portfolio strategy. Investor meetings could reduce uncertainty if management addresses outstanding questions. Sabra Health Care REIT, Inc. to Attend Citi’s 2026 Global Property CEO Conference
• Negative Sentiment: GAAP net income per diluted share for Q4 was $0.11, missing analyst estimates (~$0.37) and down from $0.36 a year ago — a near-term earnings disappointment that likely pressured the stock. Sabra: Q4 Earnings Snapshot / Earnings Release
• Negative Sentiment: Analyst commentary (BMO) flagged soft FFO outlook and uncertainty tied to an RCA loan, supporting a Hold rating — these risks could keep investor sentiment cautious until resolution or clearer guidance detail. Sabra Healthcare REIT: Solid SHOP Momentum Offset by Soft FFO Outlook and RCA Loan Uncertainty

Wall Street Analyst Weigh In

SBRA has been the topic of several recent analyst reports. Truist Financial increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a research report on Tuesday, January 20th. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 price target on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Wall Street Zen lowered shares of Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a report on Friday, January 23rd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Thursday, January 22nd. Finally, Wells Fargo & Company increased their target price on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company an “overweight” rating in a research note on Tuesday, November 25th. Four analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $21.11.

Sabra Healthcare REIT Stock Performance

The firm has a market capitalization of $5.03 billion, a PE ratio of 31.52, a price-to-earnings-growth ratio of 1.43 and a beta of 0.67. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92. The business’s 50 day simple moving average is $19.04 and its two-hundred day simple moving average is $18.76.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Thursday, February 12th. The real estate investment trust reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by ($0.26). The firm had revenue of $201.35 million during the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.66% and a net margin of 20.09%.The business’s revenue was up 16.2% on a year-over-year basis. During the same period in the previous year, the firm earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Research analysts expect that Sabra Healthcare REIT, Inc. will post 1.45 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. The ex-dividend date is Friday, February 13th. Sabra Healthcare REIT’s dividend payout ratio is 166.67%.

Institutional Trading of Sabra Healthcare REIT

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in SBRA. PNC Financial Services Group Inc. boosted its stake in shares of Sabra Healthcare REIT by 2.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock worth $451,000 after acquiring an additional 528 shares during the last quarter. Larson Financial Group LLC lifted its position in Sabra Healthcare REIT by 42.3% during the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after purchasing an additional 553 shares in the last quarter. Anchor Investment Management LLC grew its holdings in Sabra Healthcare REIT by 15.5% during the third quarter. Anchor Investment Management LLC now owns 4,150 shares of the real estate investment trust’s stock valued at $77,000 after purchasing an additional 556 shares during the period. Oppenheimer & Co. Inc. increased its position in Sabra Healthcare REIT by 1.7% in the third quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock worth $633,000 after buying an additional 581 shares in the last quarter. Finally, Journey Strategic Wealth LLC increased its position in Sabra Healthcare REIT by 3.3% in the third quarter. Journey Strategic Wealth LLC now owns 18,479 shares of the real estate investment trust’s stock worth $344,000 after buying an additional 595 shares in the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.